Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott Laboratories suspended from ABPI

Abbott Laboratories suspended from ABPI

13th February 2006

Abbott Laboratories has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for breaches of the code of practice.

The initial suspension of six months stems from complaints about inappropriate hospitality for health professionals.

ABPI president Vincent Lawton said: “The pharmaceutical industry strives to maintain the highest possible ethical standards in all its dealing with healthcare professionals. The breaches that have been identified are viewed in a very serious light, and this is reflected in the suspension ? a sanction that we have not needed to apply for many years.

“However, it is reassuring to note that Abbott also recognises the seriousness of the breaches, and has taken action to prevent their recurrence.”

Abbott has stated that it was aware of the problem before the complaint arose and had undertaken an investigation and a review of procedures. It added that the employees involved had left the company.

The complaint made in 2005, referring to actions in 2004, concerned hospitality trips, including one to greyhound racing in Manchester, where no records of who attended or what the meetings were about were kept.

track© Adfero Ltd

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.